Cite
HARVARD Citation
Soefje, S. et al. (2023). Clinical Administration Characteristics of Subcutaneous and Intravenous Administration of Daratumumab in Patients With Multiple Myeloma at Mayo Clinic Infusion Centers. JCO oncology practice. 19 (4), pp. e542-e549. [Online].